GurwitzJ.H., AvornJ., BohnR.L.. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy.JAMA.1994; 272: 781–786.
3.
VaneJ.R.. Inhibition of prostaglandin synthesis as a mechanism for aspirin-like drugs.Nat New Biol.1971; 231: 232–235.
4.
FaulknerG., PrichardP., SomervilleK.. Aspirin and bleeding peptic ulcers in the elderly.Br Med J.1988; 297: 1311–1313.
5.
GriffinM.R., PiperJ.M., DaughertyJ.R.. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.Ann Intern Med.1991; 114: 257–263.
6.
FriesJ.F., MillerS.R., SpitzP.W.. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use.J Gastroenterol.1989; 96: 647–655.
7.
LaneuvilleO., BreuerD.K., DewittD.L.. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.J Pharmacol Exp Ther.1994; 271: 927–934.
8.
GabrielS.E., JaakkimainenL., BombardierC.. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis.Ann Intern Med.1991; 115: 787–796.
JohnsonA.G.. NSAIDs and blood pressure: clinical importance for older patients.Drugs Aging.1998; 12: 17–27.
11.
JohnsonA.G., NguyenT.V., DayR.O.. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.Ann Intern Med.1994; 121: 289–300.
12.
JohnsonA.G.. NSAIDs and blood pressure. Clinical importance for older patients.Drugs Aging.1998; 12: 17–27.
13.
MeneP., PuglieseF., PatronoC.. The effects of nonsteroidal anti-inflammatory drugs on human hypertensive vascular disease.Semin Nephrol.1995; 15: 244–252.
14.
JaffeI.A.. Managing the patient at risk for NSAIDs toxicity.Scientific Therapeutics Information.Springfield, NJ: 1997: 29–32.
SimonL.S.. Nonsteroidal anti-inflammatory drugs and their effects: the importance of COX “selectivity.”J Clin Rheumatol.1996; 2: 135–140.
17.
SchiodtF.V., RochlingF.A., CaseyD.L.. Acetaminophen toxicity in an urban county hospital.N Engl J Med.1997; 337: 1112–1117.
18.
RemickR.A.. Anticholinergic side effects of tricyclic antidepressants and their management.Prog Neuropsychopharmacol Biol Psychiatry.1988; 12: 225–231.
19.
GuzzoC.A., LazarusG.S., WerthV.P.. Dermatological pharmacology. In: HardmanJ.G., LimbirdL.E., eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics.9th ed.New York, NY: McGraw-Hill, Health Professions Division; 1996: 1593–1616.